This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Ulsan Foundation for Industry Cooperation. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Treatment by Jaesook Park
Introduction
Jaesook Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the area of cancer treatment. His innovative work focuses on developing targeted therapies that can improve patient outcomes.
Latest Patents
Jaesook Park holds a patent for "Peptides for targeting colorectal cancer, and medical use thereof." This patent describes a peptide designed to target colorectal cancer effectively. The invention includes a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide. It also outlines a drug delivery method utilizing the peptide, which aims to implement personalized diagnosis and treatment for individual patients. This approach considers the varying therapeutic responses that arise from genetic differences among patients.
Career Highlights
Jaesook Park is affiliated with the University of Ulsan Foundation for Industry Cooperation. His work at this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Some of his notable coworkers include Eun Kyung Choi and Seong-Yun Jeong. Their collaborative efforts have further advanced the research and development of innovative medical solutions.
Conclusion
Jaesook Park's contributions to cancer treatment through his patented innovations highlight the importance of personalized medicine. His work not only addresses the challenges faced by cancer patients but also paves the way for future advancements in targeted therapies.